Pulmatrix Inc (PULM)

[riskon]

FEND effective Vs Delta Variant? Listen to David Himself from the 6/28 Public Discourse.

"But what happened is we were doing a study in Covid-19 patients in Banglore, and when the delta variant began to spread as rapidly as it did, the decision was made was to treat incoming patients, so randomized control study, with a nasal saline control -- was started in the February (2021) timeframe -- and we are just now submitting for publication the research.

Very high level, remarkably, treating 3-times a day of FEND, has a significant impact on lowering symptoms and also raising oxygen pressure in the blood which is a measure of your lung's ability to bring oxygen into your blood and also reduces IV/Steroid/Antibiotic use relative to the control -- so we are very hopeful that this really simple intervention could be very impact -- particularly in locations like an India today which may not have immediate access to vaccines."

Starting at 10:37-12:20

$PULM